1. de Grauw WJ, van de Lisdonk EH, Behr RR, van Gerwen WH, van den Hoogen HJ, van Weel C. The impact of type 2 diabetes mellitus on daily functioning. Fam Pract. 1999 Apr;16(2):133–9.
2. Hussain A, Claussen B, Ramachandran A, Williams R. Prevention of type 2 diabetes: a review. Diabetes Res Clin Pract. 2007 Jun;76(3):317–26.
3. Steyn NP, Mann J, Bennett PH, Temple N, Zimmet P, Tuomilehto J, et al. Diet, nutrition and the prevention of type 2 diabetes. Public Health Nutr. 2004 Feb;7(1A):147–65.
4. Ashra N, Spong R, Carter P, Davies M, Dunkley A, Gillies C, et al. A systematic review and meta analysis assessing the effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes mellitus in routine practice. London; 2015 Aug.
5. Cheung W, Luzio S. Evaluation of a Brief Lifestyle Intervention on HbA1c Values in the Afan Valley GP Cluster. 2019.
6. Gregory N. Evaluating the efficacy of a GP led pre-diabetes intervention targeting life-style modification. Aberystwyth University; 2019.
7. Gregory N, Kirkland D, Grey C, Kyle R, Jesurasa A. Developing the intervention for the All Wales Diabetes Prevention Programme. 2022.
8. Gregory N, Kirkland D, Washbrook-Davies C, Jesurasa A. The All Wales Diabetes Prevention Programme Intervention Protocol. 2022.
9. Rodgers SE, Lyons RA, Dsilva R, Jones KH, Brooks CJ, Ford D V, et al. Residential Anonymous Linking Fields (RALFs): a novel information infrastructure to study the interaction between the environment and individuals’ health. J Public Health (Oxf). 2009 Dec;31(4):582–8.
10. Rodgers SE, Demmler JC, Dsilva R, Lyons RA. Protecting health data privacy while using residence-based environment and demographic data. Health Place. 2012 Mar;18(2):209–17.
11. Ford D V, Jones KH, Verplancke JP, Lyons RA, John G, Brown G, et al. The SAIL Databank: building a national architecture for e-health research and evaluation. BMC Health Serv Res. 2009 Sep 4;9:157.
12. Lyons RA, Jones KH, John G, Brooks CJ, Verplancke JP, Ford D V, et al. The SAIL databank: linking multiple health and social care datasets. BMC Med Inform Decis Mak. 2009 Jan 16;9:3.
13. Jones KH, Ford D V, Jones C, Dsilva R, Thompson S, Brooks CJ, et al. A case study of the Secure Anonymous Information Linkage (SAIL) Gateway: a privacy-protecting remote access system for health-related research and evaluation. J Biomed Inform. 2014 Aug;50(100):196–204.
14. Parsons SN, Kosnes L, Anderson P, Harris SR, Thatcher R, Harrington B, et al. The challenges and lessons from a formative process and value-based evaluation of the wave 1 roll-out of the all Wales Diabetes Prevention Programme. BMC Public Health. 2024 Sep 13;24(1):2499.
15. Public Health Wales. Public Health Wales. 2023. 48,000 additional people with diabetes in Wales by 2035 – new analysis.
16. Bertoluci MC, Rocha VZ. Cardiovascular risk assessment in patients with diabetes. Diabetol Metab Syndr. 2017;9:25.
17. Davoudi S, Sobrin L. Novel Genetic Actors of Diabetes-Associated Microvascular Complications: Retinopathy, Kidney Disease and Neuropathy. Rev Diabet Stud. 2015;12(3–4):243–59.
18. Alwhaibi M. Depression, Anxiety, and Health-Related Quality of Life in Adults with Type 2 Diabetes. J Clin Med. 2024 Oct 10;13(20).
19. Diabetes Research Unit Cymru. Diabetes Research Unit Cymru 2019-20 Annual Report. Cardiff; 2020.
20. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet. 1992 Oct 17;340(8825):925–9.
21. American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025. Diabetes Care. 2025 Jan 1;48(1 Suppl 1):S27–49.
22. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009 Jul;32(7):1327–34.
23. Pirola L, Johnston AM, Van Obberghen E. Modulation of insulin action. Diabetologia. 2004 Feb;47(2):170–84.
24. Cai X, Xia L, Pan Y, He D, Zhu H, Wei T, et al. Differential role of insulin resistance and β-cell function in the development of prediabetes and diabetes in middle-aged and elderly Chinese population. Diabetol Metab Syndr. 2019;11:24.
25. Dansinger ML, Gleason JA, Maddalena J, Asztalos BF, Diffenderfer MR. Lifestyle Modification in Prediabetes and Diabetes: A Large Population Analysis. Nutrients. 2025 Apr 11;17(8).
26. Butler AE, English E, Kilpatrick ES, Östlundh L, Chemaitelly HS, Abu-Raddad LJ, et al. Diagnosing type 2 diabetes using Hemoglobin A1c: a systematic review and meta-analysis of the diagnostic cutpoint based on microvascular complications. Acta Diabetol. 2021 Mar;58(3):279–300.
27. Juarez DT, Demaris KM, Goo R, Mnatzaganian CL, Wong Smith H. Significance of HbA1c and its measurement in the diagnosis of diabetes mellitus: US experience. Diabetes Metab Syndr Obes. 2014;7:487–94.
28. Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials. 2007 Feb;28(2):182–91.
29. Ravindrarajah R, Reeves D, Howarth E, Meacock R, Soiland-Reyes C, Cotterill S, et al. Epidemiology and determinants of non-diabetic hyperglycaemia and its conversion to type 2 diabetes mellitus, 2000-2015: cohort population study using UK electronic health records. BMJ Open. 2020 Sep 6;10(9):e040201.